Herantis Pharma Oyj Cash Flow Quality Index
Herantis Pharma Oyj cash flow quality index. Herantis Pharma Oyj (HRTIS) has a Cash Flow Quality Index of -1.41x as of December 2023. Operating cash flow of €-2.92 Million is below net income of €2.08 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Herantis Pharma Oyj to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Herantis Pharma Oyj (2023–2023)
Cash flow quality index of Herantis Pharma Oyj from 2023 to 2023. Historical Cash Flow Quality Index for Herantis Pharma Oyj across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Herantis Pharma Oyj to assess how comfortably operating cash covers total debt obligations.
Herantis Pharma Oyj Cash Flow Quality Index by Year (2023–2023)
Herantis Pharma Oyj cash flow quality index by year from 2023 to 2023. Year-by-year earnings quality comparison for Herantis Pharma Oyj. For the full cash flow conversion analysis, see how efficiently does Herantis Pharma Oyj generate cash.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -16.57x | €-4.64 Million | €279.84K | — |